Gait analysis can improve the walk of patients with arthritis
Search results for: hip OA
American College of Rheumatology (ACR) on Capitol Hill
“By tomorrow night, there will be so many more people on Capitol Hill who know—and are sensitive to—rheumatology and the issues that impact you and your patients. There is no substitute for what you are doing,” says Martha M. Kendrick, a partner at Patton Boggs, LLP, the ACR’s lobbying firm. This is what she told the physician, health professional, and patient participants of the ACR’s 2008 “Advocates for Arthritis” advocacy event—termed a fly-in—before they took their personal stories to the lawmakers on Capitol Hill.
To Document or to Doctor? That Is the Question
Is paper pushing taking away from patient care?
Are You Informed About Informed Consent?
Physicians walk a fine line between informed consent and patient trust
Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)
A private database becomes a national resource
Reading Rheum
Handpicked Reviews of Contemporary Literature
Polymyalgia Rheumatica
Polymyalgia rheumatica (PMR) is a relatively common cause of widespread aching and stiffness in older adults. PMR can overlap with another rheumatic disease called giant cell arteritis, and symptoms of the two conditions can occur at the same time or separately. (See p. 12 of the March 2008 issue for more on giant cell arteritis.) The typical symptoms of PMR include aching and stiffness around the upper arms, neck, lower back, buttocks, and thighs. Symptoms tend to develop quickly over a period of several days or weeks, and occasionally even overnight.
Audioconference Offers Advice on Pain Associated with Juvenile Arthritis
What is the pain puzzle? “It is a bio-psycho social model of pain that is accepted in the field of rheumatology,” according to Michael Rapoff, PhD, professor of pediatrics at the University of Kansas Medical Center in Kansas City and the highlighted speaker for the ARHP audioconference on April 17.
Strength from Weakness
Perhaps physicians should look at the doors disability opens, too
The Line Between Boost and Ban
What makes a performance-enhancing drug taboo?
- « Previous Page
- 1
- …
- 308
- 309
- 310
- 311
- 312
- …
- 323
- Next Page »